Related Experiment Videos
Method for evaluating utilization of infused oligosaccharides in postsurgical patients
JPEN. Journal of Parenteral and Enteral Nutrition
|March 1, 1987
Summary
Oligosaccharides can provide energy for parenteral nutrition, but patient utilization varies. A new urine test helps identify patients who metabolize oligosaccharides effectively, aiding in personalized nutrition therapy.
Area of Science:
- Biochemistry
- Clinical Nutrition
- Medical Diagnostics
Background:
- Oligosaccharides are explored as carbohydrate energy sources for parenteral nutrition.
- Patient response to infused oligosaccharides is inconsistent, necessitating methods to assess individual utilization.
- Identifying effective utilization is crucial for optimizing parenteral nutrition strategies.
Purpose of the Study:
- To develop and validate a practical method for assessing oligosaccharide utilization in patients receiving parenteral nutrition.
- To identify patients who effectively utilize infused oligosaccharides.
- To differentiate between patients with good and poor oligosaccharide metabolism.
Main Methods:
- A novel enzymatic method using alpha-glucosidase and alpha-amylase to hydrolyze urinary oligosaccharides to glucose.
- Measurement of released glucose using a simple test tape method.
- Validation of the enzymatic method against established acid hydrolysis-spectrophotometric assays.
Main Results:
- The enzymatic test tape method demonstrated good agreement with traditional laboratory assays for oligosaccharide excretion.
- The method successfully identified postsurgical patients with poor oligosaccharide utilization in both prospective and retrospective analyses.
- This indicates the test's efficacy in distinguishing patient response to oligosaccharide infusion.
Conclusions:
- A user-friendly, ward-suitable method for assessing oligosaccharide utilization has been established.
- This method enables the identification of patients who benefit from oligosaccharides as a parenteral energy source.
- The findings support the use of oligosaccharides in selected patients based on demonstrated metabolic capacity.